Table 3 Clinical severity scores and co-morbidity rates in hospitalised patients with severe and non-severe COVID-19
Overall N = 9390 | Severe N = 721 | Non-severe N = 8669 | P-value | |
|---|---|---|---|---|
MEWS Median (IQR) | 0 (0–0) | 4 (2–6) | 0 (0–0) | < 0.0001 |
SOFA score Median (IQR) | 0 (0–0) | 0 (0–3) | 0 (0–0) | < 0.0001 |
Glasgow Coma Scale Median (IQR) | 14.9 (3–15) | 15 (15–15) | 15 (15–15) | < 0.0001 |
Co-morbiditiesa | 2706 (28.8%) | 542 (75.17%) | 2164 (24.93%) | |
Diabetes mellitus | 962 (10.24%) | 195 (27.05%) | 767 (8.85%) | < 0.0001 |
Hypertension | 1028 (10.94%) | 237 (32.87%) | 791 (9.12%) | < 0.0001 |
COPD | 3 (0.03%) | 1 (0.14%) | 2 (0.02%) | 0.095 |
Asthma | 176 (1.87%) | 16 (2.22%) | 160 (1.85%) | 0.477 |
CAD | 89 (0.95%) | 16 (2.22%) | 73 (0.84%) | 0.0002 |
Ischaemic heart disease | 93 (0.99%) | 9 (1.25%) | 84 (0.97%) | 0.466 |
CKD | 166 (1.76%) | 41 (5.69%) | 125 (1.44%) | < 0.0001 |
Malignancy | 189 (2.01%) | 27 (3.74%) | 162 (2.40%) | 0.0005 |
Pregnancy | 40 (0.43%) | 4 (0.5%) | 36 (0.4%) | 0.580 |
Body mass index Median (IQR) | 26.22 (23.83–29.34) | 25.99 (23.88–29.48) | 26.23 (23.83–29.29) | 0.589 |